Skip to main content
QinetiQ Group PLC logo

QinetiQ Group PLC — Investor Relations & Filings

Ticker · QQ ISIN · GB00B0WMWD03 LEI · 213800S8OBDOZMCMUW34 IL Professional, scientific and technical activities
Filings indexed 1,676 across all filing types
Latest filing 2022-10-12 Earnings Release
Country GB United Kingdom
Listing IL QQ

About QinetiQ Group PLC

https://www.qinetiq.com/en/

QinetiQ Group PLC is a science and engineering company that provides technology-based products and services primarily to the global defence and security sectors. The company's core activities include research and development, advisory services, and comprehensive test and evaluation (T&E) for air, land, and maritime systems. Key offerings encompass uncrewed air, land, and surface target systems for live-fire training and weapons system assessment; cybersecurity services and training; and advanced training and mission rehearsal solutions. QinetiQ focuses on mission-led innovation, applying its expertise to modernize military platforms and enhance critical technologies to address complex operational challenges for its customers.

Recent filings

Filing Released Lang Actions
Second Quarter Trading Update
Earnings Release Classification · 100% confidence The document is explicitly labeled as an 'RNS Number' release from QinetiQ Group plc, dated 12 October 2022. The title is 'Second Quarter Trading Update'. This document provides key operational and financial highlights for the second quarter (Q2) ending 30 September 2022, including order intake, revenue growth, and maintaining full-year guidance. It is a summary announcement of recent performance, not the comprehensive quarterly report itself (which is scheduled for November 10th). This fits the definition of an Earnings Release (ER), which covers initial announcements of periodical financial results (key highlights only). Although it is distributed via RNS, the content is specifically an ER. Q2 2023
2022-10-12 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the header 'RNS Number' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically the CEO, involving the purchase of company shares under an incentive plan. This type of insider transaction disclosure is a specific regulatory filing. While it relates to director dealings (DIRS), the format and source (RNS) strongly suggest it is being disseminated as a general regulatory announcement. Since the definitions include 'Director's Dealing' (DIRS) and 'Regulatory Filings' (RNS), and this is a mandatory disclosure of insider trading, DIRS is the most specific fit for the content, even though it is delivered via RNS. However, looking closely at the definitions, DIRS is for 'Report of personal share transactions by company directors and executives (insider trades)'. This document perfectly matches that description. Therefore, DIRS is the most appropriate classification.
2022-10-11 English
Acquisition of Air Affairs & disposal of Space NV
M&A Activity Classification · 99% confidence The document is clearly identified as an 'RNS Number' release from 'QinetiQ Group plc' dated '03 October 2022'. It announces specific corporate actions: the acquisition of Air Affairs and the disposal of Space NV. This type of immediate, material corporate news release, especially one originating from the London Stock Exchange's RNS service, fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category (like 10-K, ER, or IR). While it discusses strategy and M&A, the primary function here is the immediate public disclosure via the regulatory news service. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (6627 chars) is substantial enough that it is not just a brief announcement of a report, but the report itself (the M&A announcement). However, since M&A Activity (TAR) is for proposals/bids, and this is a broad regulatory announcement covering two distinct transactions and strategy updates, RNS serves as the best fit for a general, time-sensitive regulatory disclosure not covered by other specific codes.
2022-10-03 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification published via RNS (RNS Number: 1539Z) on September 12, 2022. The content explicitly details 'Notification and public disclosure of transactions by persons discharging managerial responsibilities or persons closely associated with them' (PDMR/PCA). Specifically, it reports the purchase of shares and award of matching shares under a Share Incentive Plan by the CEO, Steve Wadey. This type of insider transaction reporting is characteristic of Director's Dealing disclosures. Although it is distributed via RNS, the specific content maps directly to the Director's Dealing category (DIRS), which is more specific than the general RNS fallback.
2022-09-12 English
Group of companies' accounts made up to 2022-03-31
Regulatory Filings
2022-09-12 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document contains an 'RNS Number' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange,' which is approved by the FCA. The content details a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically the acquisition of dividend shares by the CEO, Steve Wadey. This type of insider transaction disclosure, especially when disseminated via an official regulatory news service like RNS, falls under the category of Director's Dealing (DIRS). Although RNS is mentioned, the core subject matter is the director's transaction, making DIRS more specific than the general RNS fallback.
2022-08-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.